Wuhan YZY Biopharma Management
Management criteria checks 3/4
Wuhan YZY Biopharma's CEO is Pengfei Zhou, appointed in Mar 2018, has a tenure of 6.17 years. total yearly compensation is CN¥2.31M, comprised of 86.2% salary and 13.8% bonuses, including company stock and options. directly owns 3.54% of the company’s shares, worth HK$51.18M. The average tenure of the management team and the board of directors is 3 years and 2.6 years respectively.
Key information
Pengfei Zhou
Chief executive officer
CN¥2.3m
Total compensation
| CEO salary percentage | 86.2% |
| CEO tenure | 6.2yrs |
| CEO ownership | 3.5% |
| Management average tenure | 3yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥192m |
| Jun 30 2023 | n/a | n/a | -CN¥186m |
| Mar 31 2023 | n/a | n/a | -CN¥187m |
| Dec 31 2022 | CN¥2m | CN¥2m | -CN¥189m |
| Dec 31 2021 | CN¥13m | CN¥2m | -CN¥149m |
Compensation vs Market: Pengfei's total compensation ($USD318.92K) is about average for companies of similar size in the Hong Kong market ($USD330.03K).
Compensation vs Earnings: Pengfei's compensation has been consistent with company performance over the past year.
CEO
Pengfei Zhou (56 yo)
6.2yrs
Tenure
CN¥2,308,000
Compensation
Dr. Pengfei Zhou, MD., Ph D., has been Chairman of the Board at Wuhan YZY Biopharma Co., Ltd. since September 2022 and has been its Chief Executive Officer since March 2018.He has been an Executive Direct...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 6.2yrs | CN¥2.31m | 3.54% CN¥ 51.2m | |
| Senior Vice President of Quality | 4.4yrs | no data | no data | |
| Senior Director of the R&D Center and Supervisor | no data | no data | no data | |
| Senior Manager of Strategic Development Department & Joint Company Secretary | 1.5yrs | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data |
3.0yrs
Average Tenure
48yo
Average Age
Experienced Management: 2496's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 9.6yrs | CN¥2.31m | 3.54% CN¥ 51.2m | |
| Senior Director of the R&D Center and Supervisor | 6.3yrs | no data | no data | |
| Non-Executive Director | 1.7yrs | no data | no data | |
| Non-Executive Director | 3.5yrs | no data | 0.19% CN¥ 2.8m | |
| Independent Non-Executive Director | 1.5yrs | no data | no data | |
| Non-Executive Director | 1.7yrs | no data | no data | |
| Independent Non-Executive Director | 1.5yrs | no data | no data | |
| Chairman of the Supervisory Committee | 6.3yrs | no data | no data | |
| Independent Non-Executive Director | 1.5yrs | no data | no data | |
| Non-Executive Director | 13.8yrs | no data | 5.26% CN¥ 76.0m | |
| Non-Executive Director | 13.8yrs | no data | 10.52% CN¥ 152.0m | |
| Independent Non-Executive Director | 1.5yrs | no data | no data |
2.6yrs
Average Tenure
50yo
Average Age
Experienced Board: 2496's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.